Label: ABRILADA- adalimumab-afzb injection, solution
- NDC Code(s): 61434-053-00
- Packager: Catalent Indiana, LLC
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: Export only
Drug Label Information
Updated November 9, 2022
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
ABRILADA
adalimumab-afzb injection, solutionProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:61434-053 Route of Administration SUBCUTANEOUS Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ADALIMUMAB-AFZB (UNII: FYS6T7F842) (ADALIMUMAB - UNII:FYS6T7F842) ADALIMUMAB-AFZB 20 mg in 0.4 mL Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:61434-053-00 40 in 1 CASE 01/14/2021 1 2 in 1 CARTON 1 0.4 mL in 1 SYRINGE; Type 3: Prefilled Biologic Delivery Device/System (syringe, patch, etc.) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date export only 01/14/2021 Labeler - Catalent Indiana, LLC (172209277)